Quick Summary
Ligustrum lucidum, also known as glossy privet, is a traditional Chinese medicine herb commonly used as part of multi-herb formulas. It has a history of application in conditions including cancer, osteoporosis, diabetes, and immune-related disorders. Preclinical studies and some clinical investigations suggest it may have multiple biological activities such as anti-inflammatory, antioxidant, immunomodulatory, and bone-protective effects. However, clinical evidence remains preliminary and mostly indirect, often reported as a component of complex traditional formulas rather than isolated Ligustrum lucidum.
What is it
Ligustrum lucidum is a plant species used in traditional Chinese medicine (TCM). It belongs to the Oleaceae family and is commonly referred to as glossy privet. The dried fruit of this plant is also known as “Nu Zhen Zi” in Chinese herbal therapy and is often used in combination with other herbs.
Traditional Uses
- Part of multi-herb TCM formulas for cancer support
- Management of osteoporosis
- Support in diabetes and diabetic complications
- Enhancement of immune function and treatment of immune-inflammatory disorders
Active Compounds
Ligustrum lucidum contains various phytochemicals believed to contribute to its biological effects. While specific active compounds are under investigation, constituents with antioxidant, anti-inflammatory, and immunomodulatory properties have been identified. Detailed compound profiles are often reported in molecular studies but are less clearly defined in human clinical contexts.
Potential Benefits with Evidence Levels
- Hepatocellular carcinoma (HCC): Traditional Chinese Medicine including Ligustrum lucidum extracts shows promising preclinical mechanisms such as tumor growth inhibition and immune enhancement. However, larger, rigorous clinical trials are needed for validation. (Jia X et al., 2026)
- Osteoporosis: Ligustrum lucidum derivatives may have potential benefits in osteoporosis management based on preclinical and molecular mechanism studies, but direct human clinical trial evidence is lacking. (Yan S et al., 2026; Yang X et al., 2025; Zhou T et al., 2026)
- Cancer adjunctive therapy: Some commercial Chinese polyherbal preparations containing Ligustrum lucidum have demonstrated efficacy and immune improvements when combined with chemotherapy in gastric, lung, and colorectal cancers. The evidence primarily involves multi-herb formulas rather than Ligustrum lucidum alone. (Pan B et al., 2025; Lee KJ et al., 2025; Wang M et al., 2025)
- Diabetes and diabetic complications: Ligustrum lucidum is included in TCM interventions that show potential benefits in diabetes management and diabetic complications such as retinopathy and kidney disease. Clinical evidence is preliminary and typically combined with other herbs. (Liu Y et al., 2025; Fan Y et al., 2026; Li HD et al., 2023)
- Immune and inflammatory disorders: TCM containing Ligustrum lucidum has shown immunomodulatory effects in autoimmune and inflammatory conditions (e.g., immune thrombocytopenia, rheumatoid arthritis), mainly supported by preclinical studies and traditional use; limited clinical evidence is available. (Zhou X et al., 2026; Yang R et al., 2026)
Side Effects
Current clinical data do not highlight specific adverse effects attributable to Ligustrum lucidum alone. Adverse effects reported in polyherbal formulations containing Ligustrum lucidum are generally mild and typically related to other components or conventional therapies. No serious safety concerns or severe adverse events specifically linked to Ligustrum lucidum have been reported in clinical studies.
Drug Interactions
There is no direct evidence of drug interactions involving Ligustrum lucidum. However, caution is advised when combining it with chemotherapeutic agents or other pharmaceuticals, as some interactions have been reported for traditional Chinese medicine formulas containing multiple herbs.
Who Should Avoid It
- Pregnant and breastfeeding individuals should avoid using Ligustrum lucidum due to insufficient safety data.
- People on chemotherapy or other medications should consult healthcare professionals before using products containing Ligustrum lucidum.
- Individuals with allergies to herbal components should exercise caution.
Evidence Limitations
- Most clinical evidence involves Ligustrum lucidum as part of multi-herb TCM formulas rather than in isolation, making it difficult to attribute effects solely to this herb.
- Few large-scale, high-quality randomized controlled trials specifically evaluating Ligustrum lucidum in humans exist.
- Many studies are preclinical or animal-model based, limiting direct clinical translation.
- Reported beneficial effects often derive from complex combinations where standardization and quality control vary.
- Safety and long-term effects require further rigorous investigation.
References
- Jia X et al. (2026). How Traditional Chinese Medicine Works: Biological Mechanisms and Clinical Evidence for Hepatocellular Carcinoma Treatment.
- Yan S et al. (2026). Traditional Chinese Medicine for osteoporosis management: from molecular mechanisms to drug discovery.
- Pan B et al. (2025). Efficacy and safety of commercial Chinese polyherbal preparation combined with oxaliplatin-based chemotherapy for gastric cancer: a systematic review and network meta-analysis.
- Lee KJ et al. (2025). Efficacy of Herbal Medicine Therapy Combined With Palliative Chemotherapy in Unresectable Advanced NSCLC: A Systematic Review and Meta-Analysis.
- Liu Y et al. (2025). Tianqi Jiangtang Capsule in the treatment of patients with diabetes: a systematic review and meta-analysis.
- Fan Y et al. (2026). Traditional Chinese medicine in diabetes management: a comprehensive review of mechanisms and therapeutic potential.
- Zhou X et al. (2026). Integrating ‘Yang transforming Qi and Yin constituting the body’ with immune regulation: an evidence synthesis of multidimensional traditional chinese medicine therapy for immune thrombocytopenia.
- Yang R et al. (2026). Ferroptosis as a therapeutic nexus: traditional Chinese medicine interventions in rheumatoid arthritis.
- Hui J et al. (2025). Potential preventive effects of selected traditional Chinese medicine as adjuvant therapy on hypertensive heart disease progression by replenishing qi and activating blood circulation: a systematic review and meta-analysis of clinical trials.
- Gao H et al. (2025). Oleanolic acid@SPIONs Alleviates Lipid-Oxidative Stress Injury of Zebrafish Blood Vessels via Regulating the Expression of JNK and MAPK Signaling Pathways in Vascular Endothelial Cells.
- Yan H et al. (2024). Effectiveness of adjuvant traditional Chinese medicine on macrovascular invasion in patients with hepatocellular carcinoma: a real-world propensity score-matched study.
Last Reviewed
June 2024
Disclaimer: This information is for educational purposes only and is not intended as medical advice. Always consult a healthcare professional before using herbs or supplements, especially if you are pregnant, nursing, have a medical condition, or are taking medications. The efficacy and safety of Ligustrum lucidum require further research, and its use should be approached with caution.